Aaron Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8M Buy
11,530
+277
+2% +$283K 0.7% 21
2026
Q1
$10.4M Sell
11,253
-943
-8% -$956K 0.59% 29
2025
Q4
$13.1M Buy
12,196
+2,193
+22% +$2.1M 0.72% 23
2025
Q3
$7.63M Buy
10,003
+4,392
+78% +$3.27M 0.45% 31
2025
Q2
$4.37M Sell
5,611
-41
-0.7% -$31.9K 0.45% 33
2025
Q1
$4.67M Buy
5,652
+533
+10% +$444K 0.54% 31
2024
Q4
$3.95M Sell
5,119
-285
-5% -$236K 0.46% 35
2024
Q3
$4.79M Buy
5,404
+690
+15% +$620K 0.57% 26
2024
Q2
$4.27M Buy
4,714
+208
+5% +$166K 0.59% 25
2024
Q1
$3.51M Buy
4,506
+951
+27% +$677K 0.5% 30
2023
Q4
$2.07M Sell
3,555
-2,457
-41% -$1.43M 0.34% 39
2023
Q3
$3.23M Buy
6,012
+685
+13% +$353K 0.42% 40
2023
Q2
$2.5M Buy
5,327
+226
+4% +$94.8K 0.32% 50
2023
Q1
$1.75M Sell
5,101
-7,338
-59% -$2.47M 0.24% 66
2022
Q4
$4.55M Sell
12,439
-59
-0.5% -$20.9K 0.66% 34
2022
Q3
$4.04M Buy
12,498
+10,321
+474% +$3.27M 0.75% 33
2022
Q2
$705K Sell
2,177
-345,476
-99% -$104M 0.18% 77
2022
Q1
$1.21M Buy
347,653
+345,790
+18,561% +$89M 0.02% 317
2021
Q4
$514K Buy
1,863
+490
+36% +$124K 0.14% 95
2021
Q3
$317K Buy
1,373
+35
+3% +$8.64K 0.09% 122
2021
Q2
$307K Sell
1,338
-214
-14% -$43K 0.1% 124
2021
Q1
$289K Sell
1,552
-49
-3% -$9.59K 0.11% 118
2020
Q4
$270K Buy
+1,601
New +$239K 0.1% 110

Other funds holding LLY

Aaron Wealth Advisors's LLY Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $283K and bringing the position to 11,530 shares worth $13.8M. The position accounts for 0.7% of the portfolio, ranked #21.

Aaron Wealth Advisors first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aaron Wealth Advisors held 11,530 shares of Eli Lilly worth $13.8M as of Q2 2026.
  • Aaron Wealth Advisors bought 277 Eli Lilly shares in Q2 2026, an estimated $283K.
  • Eli Lilly made up 0.7% of Aaron Wealth Advisors's portfolio in Q2 2026, its #21 holding.
  • Aaron Wealth Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.